Zenotech Laboratories Limited (BOM:532039)

India flag India · Delayed Price · Currency is INR
45.43
-1.27 (-2.72%)
At close: Apr 28, 2026
-21.69%
Market Cap 2.77B
Revenue (ttm) 419.33M
Net Income (ttm) 33.62M
Shares Out 61.03M
EPS (ttm) 0.55
PE Ratio 82.63
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,857
Average Volume 12,965
Open 46.70
Previous Close 46.70
Day's Range 45.10 - 46.70
52-Week Range 33.55 - 72.87
Beta 0.09
RSI 51.61
Earnings Date Apr 29, 2026

About Zenotech Laboratories

Zenotech Laboratories Limited manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India. It offers contract manufacturing services for parenteral depot formulations, ophthalmic, oncology oral and injectables, and general injectables. The company also leases out its biotech facility and equipment. In addition, it provides granulocyte-colony stimulating factor and granulocyte-macrophage colony-stimulating factor products. Zenotech Laboratories Limited was incorporated in 1989 and is ... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1989
Employees 228
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532039
Full Company Profile

Financial Performance

In fiscal year 2025, Zenotech Laboratories's revenue was 390.98 million, an increase of 6.22% compared to the previous year's 368.09 million. Earnings were 56.13 million, a decrease of -32.36%.

Financial Statements

News

There is no news available yet.